The researchers placed 20 volunteers into two groups. One group received 40mg of resveratrol and the other took a placebo, once a day for 6 weeks.
Blood samples were taken at the start of the trial and then at intervals throughout the rest of the study. The results showed that the resveratrol suppressed the build up of oxidative stress, caused by free radicals - which release pro-inflammatory substances in the blood stream.
The author of the study Husam Ghanim, PhD, says that the extract reduces the rate of aging due to its ability to activate a group of genes called Sirtuins, which are associated with longevity. He also went on to say that they have found that resveratrol reduces the inflammation that is usually associated with stroke, heart disease and type 2 diabetes. All diseases caused by activation of the inflammatory protein, tumor necrosis factor (TNF)
James Betz, CEO of bioceutical firm, Biotivia said: "This evidence supports research that we collaborated on with the Albert Einstein School of Medicine and Ottawa Hospital. The Albert Einstein study investigated resveratrol's effect on impaired glucose tolerance (IGT) and pre-diabetes and the results found that it increased insulin resistance." A second study at the same institution concluded that resveratrol enhanced mitochondrial function, an important property vis-a-vis the prevention and treatment of a number of human health conditions usually associated with aging."
Resveratrol is a naturally occurring phytoalexin that is found in plants whose function is to protect against attack from bacteria, fungi and other environmental stresses and threats. It is basically the plants immune system and is activated by stress and other harmful agents. The theory of zenohormesis postulates that a compound such as resveratrol, which protects plants can impart similar protection to animals, such as humans, who consume it.
Betz continued: "As more and more human clinical trials are undertaken into the effects of resveratrol, researchers are adding to their knowledge of this extraordinary compounds effects. Our resveratrol is 98% pure trans-resveratrol with both a 250mg 500mg strength supplement. Biotivia recently introduced the only true time release high-potency resveratrol supplement, Transmax TR, which provides a constant release of resveratrol into your blood plasma over a period of up to 24 hours"
The study is published online in advance of an upcoming print issue of the Journal of Clinical Endocrinology & Metabolism
To know more about resveratrol supplements and their health applications please visit: http://www.biotivia.com
About Biotivia LLC
Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and botanicals to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world's leading developers and suppliers of potent nutritional supplements and skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.
Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi'an, China and Mumbai, India.
Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center and the University of California. Transmax and Bioforte in particular are being explored by several major universities as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers.
Biotivia's resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both 'most potent' and 'best value'.
Most of Biotivia's other supplements have been certified Vegan by the American Vegetarian Association.
Neither Transmax nor any Biotivia product has been shown to prevent diabetes or any other disease. Transmax TR is not intended to diagnose, prevent, treat or cure any disease. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art FDA inspected pharmaceutical facilities in accordance with CGMP USP standards.
Contact information:
Leo Day
leo.biotivia@gmail.com